---
figid: PMC7391668__41392_2020_199_Fig1_HTML
figlink: pmc/articles/PMC7391668/figure/Fig1/
number: F1
caption: The VEGF, PI3K/AKT/mTOR, and Ras/Raf/MEK signal transduction pathway and
  therapeutic interventions. After ligand binding, the receptors initiate the signaling
  cascade reaction, which is overactive in cancer cells. The figure shows the main
  elements in those pathways and the therapeutic agents
pmcid: PMC7391668
papertitle: 'Targeted therapies in gynecological cancers: a comprehensive review of
  clinical evidence.'
reftext: Qiao Wang, et al. Signal Transduct Target Ther. 2020;5:137.
pmc_ranked_result_index: '8418'
pathway_score: 0.9330844
filename: 41392_2020_199_Fig1_HTML.jpg
figtitle: VEGF, PI3K/AKT/mTOR, and Ras/Raf/MEK signal transduction pathway and therapeutic
  interventions
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7391668__41392_2020_199_Fig1_HTML.html
  '@type': Dataset
  description: The VEGF, PI3K/AKT/mTOR, and Ras/Raf/MEK signal transduction pathway
    and therapeutic interventions. After ligand binding, the receptors initiate the
    signaling cascade reaction, which is overactive in cancer cells. The figure shows
    the main elements in those pathways and the therapeutic agents
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FLT1
  - FLT4
  - KDR
  - PDGFRB
  - PDGFRA
  - EGFR
  - KIT
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - ARAF
  - BRAF
  - RAF1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - MTOR
  - Pazopanib
  - Nintedanib
  - Cediranib
  - Sorafenib
  - Selumetinib
  - Temsirolimus
genes:
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: c-kit
  symbol: KIT
  source: hgnc_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals:
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: Nintedanib
  source: MESH
  identifier: C530716
- word: Cediranib
  source: MESH
  identifier: C500926
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Selumetinib
  source: MESH
  identifier: C517975
- word: Temsirolimus
  source: MESH
  identifier: C401859
diseases: []
figid_alias: PMC7391668__F1
redirect_from: /figures/PMC7391668__F1
figtype: Figure
---
